Home Multimedia Podcasts Four-Stranded DNA May Aid in Developing Targeted Cancer Therapies Four-Stranded DNA May Aid in Developing Targeted Cancer Therapies September 22, 2016 Quadruple helices appear to have role in switching genes on or off. /wp-content/uploads/2018/09/SoundsOfScience_Sterling-9_22_16.mp3 PodcastsResourcesCancer therapyCellular, Molecular and Developmental BiologyDNAMedicine, Diagnosis, and TherapeuticsMolecular biologyNucleic acidsTherapeutics Also of Interest HIV-Free Hopes Raised by Reservoir-Targeting VLPs Rising from the Ashes: FDA Grants EUA to Invivyd COVID-19 Antibody Novo Nordisk to Acquire Cardior for Up to $1.1B, Boosting Cardiovascular Pipeline StockWatch: CDMOs Tumble as Congress Takes Aim at Chinese Biotechs Weak Spot of Lung Cancer Protein Uncovered 10x Ships First Single Cell GEM-X Assays to Customers Related Media Carl Icahn States His Case for Change at Illumina on "Close to the Edge" Celebrating DNA: Matthew Cobb's Reflections on the Double Helix Emerging Markets Collaborate to Succeed in Post-Pandemic World The Sun Sets on AGBT: A Report from the Last Day Spatial, Sequencing, and Sun: A Report from Day 2 of AGBT Sand, Sea, and Sequencing: Julianna LeMieux Surfs up AGBT's Hot News Related Content HIV-Free Hopes Raised by Reservoir-Targeting VLPs Rising from the Ashes: FDA Grants EUA to Invivyd COVID-19 Antibody Novo Nordisk to Acquire Cardior for Up to $1.1B, Boosting Cardiovascular Pipeline StockWatch: CDMOs Tumble as Congress Takes Aim at Chinese Biotechs